Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the mosquito borne diseases market?

The market size for diseases transmitted by mosquitoes has significantly expanded in the past few years. It is anticipated to elevate from $3.06 billion in 2024 to $3.31 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. The historical growth is largely due to the escalating incidence of malaria and dengue, global warming, insufficient public health facilities, urbanization and population surge, and heightened consciousness about healthcare.

What will be the mosquito borne diseases market size in the future?

The market for diseases transmitted by mosquitoes is anticipated to experience robust growth in the upcoming years, reaching a valuation of $4.51 billion by the year 2029, boasting an impressive compound annual growth rate (CAGR) of 8.0%. The trajectory of growth during the forecast period is believed to be a product of factors such as increased funding for vector control programs, enhanced focus on healthcare infrastructure, growth in travel and tourism to disease-prone areas, the surfacing of drug-resistant mosquito species, and disease-elimination initiatives by governments. The forecast period is also expected to witness trends like the creation of insecticide-treated bed nets, the launch of quick diagnostic testing kits, progress in methods of vector control, technological advancements, and the creation of superior diagnostic tools.

Get your mosquito borne diseases market report here!

https://www.thebusinessresearchcompany.com/report/mosquito-borne-diseases-global-market-report

What main drivers are fueling expansion in the mosquito borne diseases market?

The mosquito borne diseases market is projected to expand owing to the rise in international travel. The boost in international travel is attributable to a heightened need for leisure activities, business trips, and post-pandemic reunions, along with enhanced access and better travel facilities. This type of travel intensifies the spread of mosquito-borne diseases by heightening interaction with mosquito habitats, easing the migration of mosquitos carrying diseases, and impeding useful vector control strategies. For example, UN Tourism, a Spain-based tourism firm, reported approximately 1.1 billion global tourist arrivals (overnight visitors) from January to September 2024, reflecting an approximately 11% increase from the matching period in 2023. As a result, the mosquito borne diseases market is benefiting from the escalation in international travel.

What key areas define the segmentation of the global mosquito borne diseases market?

The mosquito borne diseases market covered in this report is segmented –

1) By Disease Type: Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus, Other Disease Types

2) By Treatment Type: Medication, Vaccination, Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types

3) By End User: Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, Non-Governmental Organizations, Other End Users

Subsegments:

1) By Malaria: Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types

2) By Dengue: Dengue Fever, Severe Dengue (Dengue Hemorrhagic Fever)

3) By Yellow Fever: Acute Yellow Fever, Chronic Yellow Fever

4) By West Nile Virus: Neuroinvasive Disease (Encephalitis, Meningitis), Non-neuroinvasive Disease

5) By Chikungunya: Acute Chikungunya, Chronic Chikungunya

6) By Zika Virus: Acute Zika Infection, Congenital Zika Syndrome

7) By Other Disease Types: Japanese Encephalitis, La Crosse Encephalitis, Eastern Equine Encephalitis (EEE), Other Mosquito-Borne Infections

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20888&type=smp

Who are the dominant players expanding their reach in the mosquito borne diseases market?

Major companies operating in the mosquito borne diseases market are Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Syngenta, Takeda Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India Pvt. Ltd., Orkin Inc., RTI International, Emergent BioSolutions, Valneva SE, BioCryst Pharmaceuticals Inc., Bharat Biotech, Vector Control International, Clarke Environmental Mosquito Management, Inovio Pharmaceuticals, Oxitec Ltd.

What emerging trends are influencing the growth of the mosquito borne diseases market?

Major companies operating in the mosquito-borne diseases market are focusing on developing innovative products, such as advanced mosquito repellents, to enhance the effectiveness of protection against diseases such as malaria, dengue, and Zika. Advanced mosquito repellents refer to innovative products that use long-lasting, effective ingredients or technologies, such as microencapsulation, natural compounds, or wearable devices, to provide enhanced protection against mosquitoes. For instance, in March 2023, Mortein, an Australia-based household insecticide brand, launched Mortein Smart+, a cutting-edge liquid vaporizer designed to offer protection against mosquitoes. This product provides two hours of residual protection even after being turned off, addressing the rising threat of mosquito-borne diseases with quicker and more effective repellency. The launch highlights Mortein’s dedication to offering reliable solutions for families, particularly in the fight against mosquito-borne illnesses.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20888

Which regions are emerging as leaders in the mosquito borne diseases market?

North America was the largest region in the mosquito borne diseases market in 2024. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in the mosquito borne diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Liver Diseases Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Rare Diseases Treatment Global Market Report 2025

https://thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Kidney Diseases Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/rare-kidney-diseases-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: